Equities research analysts expect Teleflex Incorporated (NYSE:TFX) to report $2.02 earnings per share for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for Teleflex’s earnings, with the highest EPS estimate coming in at $2.08 and the lowest estimate coming in at $1.98. Teleflex reported earnings per share of $1.80 during the same quarter last year, which would indicate a positive year over year growth rate of 12.2%. The company is expected to issue its next earnings report on Thursday, October 26th.

On average, analysts expect that Teleflex will report full year earnings of $8.29 per share for the current year, with EPS estimates ranging from $8.18 to $8.35. For the next financial year, analysts expect that the business will post earnings of $9.67 per share, with EPS estimates ranging from $9.54 to $9.94. Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that follow Teleflex.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.13. The business had revenue of $528.60 million during the quarter, compared to the consensus estimate of $518.98 million. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.89 earnings per share.

TFX has been the subject of a number of research analyst reports. Zacks Investment Research lowered Teleflex from a “buy” rating to a “hold” rating in a research report on Thursday, August 31st. Leerink Swann raised Teleflex from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $227.00 to $266.00 in a research report on Thursday, September 7th. Barclays PLC reaffirmed a “buy” rating on shares of Teleflex in a research report on Monday, June 26th. Deutsche Bank AG reaffirmed a “buy” rating and set a $238.00 target price (up from $220.00) on shares of Teleflex in a research report on Wednesday, August 9th. Finally, Jefferies Group LLC lifted their target price on Teleflex from $253.00 to $270.00 and gave the company a “buy” rating in a research report on Friday, September 8th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the stock. Teleflex currently has a consensus rating of “Buy” and an average price target of $260.75.

COPYRIGHT VIOLATION WARNING: This story was originally published by Daily Political and is the property of of Daily Political. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.dailypolitical.com/2017/10/18/teleflex-incorporated-tfx-expected-to-post-earnings-of-2-02-per-share.html.

In other news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $241.88, for a total value of $48,376.00. Following the completion of the transaction, the director now directly owns 8,080 shares of the company’s stock, valued at approximately $1,954,390.40. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Over the last three months, insiders sold 600 shares of company stock valued at $132,408. Corporate insiders own 2.39% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Atlanta Capital Management Co. L L C raised its position in shares of Teleflex by 2.6% in the 2nd quarter. Atlanta Capital Management Co. L L C now owns 2,519,464 shares of the medical technology company’s stock worth $523,444,000 after acquiring an additional 64,985 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Teleflex by 50,429.2% in the 2nd quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock worth $377,296,000 after acquiring an additional 1,812,426 shares in the last quarter. State Street Corp raised its position in shares of Teleflex by 1.8% in the 2nd quarter. State Street Corp now owns 1,399,922 shares of the medical technology company’s stock worth $290,853,000 after acquiring an additional 25,401 shares in the last quarter. Koch Industries Inc. raised its position in shares of Teleflex by 47,174.3% in the 2nd quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after acquiring an additional 957,639 shares in the last quarter. Finally, American Century Companies Inc. raised its position in shares of Teleflex by 22.8% in the 2nd quarter. American Century Companies Inc. now owns 839,080 shares of the medical technology company’s stock worth $174,327,000 after acquiring an additional 155,863 shares in the last quarter. 89.75% of the stock is owned by hedge funds and other institutional investors.

Teleflex (NYSE TFX) opened at 240.76 on Wednesday. Teleflex has a 12-month low of $136.53 and a 12-month high of $248.68. The firm has a 50-day moving average price of $233.66 and a 200-day moving average price of $211.26. The company has a market cap of $10.84 billion, a P/E ratio of 46.04 and a beta of 1.07.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Get a free copy of the Zacks research report on Teleflex (TFX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.